Hypopituitarism
Partial or complete deficiency of anterior or posterior pituitary hormone production leads to
central hypoadrenalism, central hypothyroidism, hypogonadotropic hypogonadism, growth …
central hypoadrenalism, central hypothyroidism, hypogonadotropic hypogonadism, growth …
Postsurgical outcomes of nonfunctioning pituitary adenomas: A patient-level meta-analysis
KY Fong, MJR Lim, S Fu, CE Low, YH Chan… - Pituitary, 2023 - Springer
Background Surgical resection is the main treatment for symptomatic nonfunctioning
pituitary adenomas (NFPA). We aimed to analyze the impact of surgical approach …
pituitary adenomas (NFPA). We aimed to analyze the impact of surgical approach …
Long-term radiographic and endocrinological outcomes of stereotactic radiosurgery for recurrent or residual nonfunctioning pituitary adenomas
OBJECTIVE Stereotactic radiosurgery (SRS) is used for the treatment of residual/recurrent
nonfunctional pituitary adenoma (NFPA). The aim of this study was to evaluate the factors …
nonfunctional pituitary adenoma (NFPA). The aim of this study was to evaluate the factors …
Volumetric assessment of nonfunctional pituitary adenoma treated with stereotactic radiosurgery: an assessment of long-term response
S Dayawansa, SO Abbas, G Mantziaris, C Dumot… - …, 2023 - journals.lww.com
METHODS: Two providers independently performed volumetric analyses on 54 patients who
underwent single-session SRS for a recurrent/residual NFPA. In the case of discrepancy …
underwent single-session SRS for a recurrent/residual NFPA. In the case of discrepancy …
Stereotactic radiosurgery for recurrent/residual nonfunctioning pituitary adenoma: a single-arm systematic review and meta-analysis
Abstract Background Nonfunctioning pituitary adenomas (NFPAs) are a significant subtype
of pituitary tumors, accounting for 30% of all pituitary tumors and 10–20% of intracranial …
of pituitary tumors, accounting for 30% of all pituitary tumors and 10–20% of intracranial …
Silent corticotroph staining pituitary neuroendocrine tumors: prognostic significance in radiosurgery
METHODS: This retrospective, multicenter study included patients managed with SRS for
NFpitNET residuals. The patients were divided into 2 cohorts:(1) silent corticotroph (SC) for …
NFpitNET residuals. The patients were divided into 2 cohorts:(1) silent corticotroph (SC) for …
Stereotactic Radiosurgery and Fractionated Radiation therapy in the management of pituitary tumors
Pituitary tumors require a diverse, multidisciplinary approach in their management.
Stereotactic radiosurgery (single or hypofractionated) and fractionated radiotherapy are …
Stereotactic radiosurgery (single or hypofractionated) and fractionated radiotherapy are …
Management of residual nonfunctioning pituitary adenoma: watchful waiting or adjuvant treatment?
L Albano, M Losa, LR Barzaghi, P Mortini - Journal of Neurosurgery, 2023 - thejns.org
TO THE EDITOR: I read with interest the article by Kong et al. 1 (Kong DS, Kim YH, Lee WJ,
et al. Indications and outcomes of endoscopic transorbital surgery fo r trigeminal …
et al. Indications and outcomes of endoscopic transorbital surgery fo r trigeminal …
Early Versus Delayed Fractionated Stereotactic Radiotherapy for Nonfunctioning Pituitary Adenoma
AV Sathe, A Siu, KC Kang, A Kayne, S Vinjamuri… - World Neurosurgery, 2023 - Elsevier
Background Fractionated stereotactic radiotherapy (FSRT) is a common modality used to
treat pituitary adenomas with good control rates. It is not known whether FSRT should be …
treat pituitary adenomas with good control rates. It is not known whether FSRT should be …
Pituitary Neuroendocrine Tumors (PitNETs)/Pituitary Adenomas
CM DeCesaris, LM Burt, D Cannon… - Adult CNS Radiation …, 2024 - Springer
Pituitary neuroendocrine tumors (PitNETs)/pituitary adenomas are common neoplasms of
the brain estimated to represent approximately 15–20% of all intracranial neoplasms …
the brain estimated to represent approximately 15–20% of all intracranial neoplasms …